Mr. Gregory P. Pilant
Director, Chairman of the Board, Chief Executive Officer
Greg Pilant is the founder, CEO, and Chairman of a number of private companies. Mr. Pilant is a lifelong entrepreneur and founder and Chairman of Greystone Pharmaceuticals, Inc. Prior to Greystone he was CEO of Medical and Pharma Companies since 1985 including Stanley Pharmaceuticals, National labs, and MedStat. Mr. Pilant has set-up manufacturing facilities in United States, China, Europe and the Middle East, and has had 30 years of experience in every aspect of wound care from FDA and CE compliance reimbursement, manufacturing and distribution. Mr. Pilant was one the of first fifteen voted into University of Memphis “Business Hall of Fame”.
Mr. Kenneth W. Perry
Chief Financial Officer
Kenneth Perry is a seasoned CFO and senior finance executive with 39 years of experience in healthcare finance, revenue cycle management, supply chain operations, and information technology. With extensive leadership experience in the medical field, Ken has served as Division CFO for HCA, founded Lasis Healthcare, and led multiple healthcare organizations to financial success. His expertise spans system implementations and strategic leadership. Ken’s balanced approach to problem-solving is strengthened by his rare combination of finance, operations, IT knowledge and general accounting for public companies. A multiple award-winning CFO, he consistently delivers exceptional results, meeting KPIs and financial targets. Ken holds an MBA in Finance from Mississippi State University and a BS in Accounting from Tennessee Technological University.
Dr. Lee Ori
Director, Chief Research & Development Officer, Secretary/Treasurer
Dr. Lee Ori graduated from Auburn University Harrison School of Pharmacy (AUHSOP) magna cum laude with his doctorate in pharmacy. He worked for Eli Lilly and Company as a clinical liaison to physicians. Lee presently holds pharmacist license(s) in 10 states and has held numerous executive positions based on his extensive compounding background. These include serving as Director or Pharmaceutical Operations for Optimal Health Labs, LLC, and Chief Medical Officer for Ready Scrip, LLC.
Mr. Gary Pilant
Vice President of Finance
Gary Pilant has successfully founded several private companies. His strategic efforts as the Founder and CEO have resulted in numerous financially successful ventures including Paragon Essential, a 140-employee company that manufactures OTC medical products of which he sold. Additionally, he founded both Cre8stone, a manufacturer of high-end construction materials and DGH Pharma, a pharmaceutical company with worldwide sales. Gary brings a wealth of knowledge and extensive experience in corporate finance and executive leadership to his role as Vice President of Finance at Regenerex.
Ms. Deborah Pilant
Controller
Deborah Pilant is Founder and CEO of a regional construction company. Debe’s experience includes ten years as Vice-President of sales and marketing with a national book manufacturer as well as twenty years in education and supervision with the Tennessee Board of Education. Ms. Pilant has a Masters Degree in Education, and an Ed.S. in Instructional Leadership.
Samuel Lee
Chief Operations Officer
Samuel Lee is a healthcare leader with expertise in multiple areas of the healthcare industry. He has served as SVP at Healogics and as a consultant.
In the past 20 years of his career, Samuel has led and managed 9 Area Vice Presidents, 5 Regional Directors of Clinical Operations and Regional Revenue Cycle Managers for Healogics. In addition, he was accountable for 120 outpatient Wound Care and Hyperbaric Centers and 50+ providers in 11 states and Puerto Rico accounting for annual revenue more than $60M. Samuel led 70 centers recognized as Centers of Distinction and/or Centers of Excellence and spearheaded strategic initiatives and strategic alignment with hospital and physician partners, exceeding quality targets, expanding market penetration, and improving financial return. He directed contracting, implementation, and profitability for Specialty Physician practices that included ~50 physicians and allied providers, doubling the market footprint and increasing practice revenue over 200%, and was awarded Outstanding Senior Vice President of the Year for 2017.
Mr. R. Dan Winnett
Executive Vice President and In-house Counsel
Dan Winnett graduated cum laude from Southern Illinois University School of Law in 1983. From 1983 through 1995 he specialized in complex litigation with an emphasis on intellectual property and business relationships. From 1995 to present, he has been involved in the management of start-up medical ventures. He has served as In-house Counsel to H. E. Stanley Pharmaceutical, a Florida based research and development pharmaceutical company and later for Greystone. From 1996 to 2000, Mr. Winnett was CEO of Hyperion Medical, a medical device manufacturing company specializing in wound care products.
Mr. Damon Faulkner
Vice President Sales and Marketing
Damon Faulkner is an award-winning sales management professional with a proven record for leading multi-million dollar campaigns for advanced wound care products. He has been responsible for all aspects of developing sales, key opinion leaders, and managing new product introduction campaigns. As a Director for Smith & Nephew’s Wound Care Division, he oversaw the launch of Acticoat (a nanocrystalline silver delivery system for broad spectrum antimicrobials) and Dermagraft (a human fibroblast derived dermal tissue indicated for the treatment of diabetic foot ulcers).
Dr. Christopher Hendrix, DPM
Clinical Director
Dr. Hendrix is Board Certified by both the American Board of Podiatric Surgery and the American Academy of Wound Management. Dr. Hendrix treats a wide variety of foot and ankle maladies, but his professional interests focus on limb salvage, wound care and closure, trauma, and reconstructive techniques.
Ms.Tasha D. Kennon, RN, BS, CDCES, CDFS
Clinical Training Director
Tasha Kennon is a Registered Nurse, has a Bachelor’s degree in Science and Health Arts, is a Certified Diabetes Educator, and a Certified Wound and Foot Care Specialist. Her career roles have included trauma nurse, home health, medical device and pharmaceutical sales, leading medical education for peripheral arterial disease and limb salvage, and a consultant in wound care and diabetes.
She has served as Director of Operations for over 40 employees, and Regional Director for Performance Improvement where she traveled across the U.S. writing protocols, training, educating staff, and making recommendations for wound treatment. Ms. Kennon has been responsible for assisting with clinical studies, protocols, treatment recommendations, training and education, and launching medical technologies internationally.
Mr. John Nycz
Marketing Director
John Nycz has stacked a 20-year marketing career on top of deep experience in B2B, high-ticket, long-cycle, complex sales pursuits spanning Healthcare (medical device, cardiac surgical supply, wound care, and bioelectronics), software, operational excellence, and marketing technology verticals. In his current role, John works with fellow exec team members to develop and deploy marketing strategy, leveraging traditional marketing tools combined with CRM, marketing automation, and business analytics to support sales. He is also passionate about tech advances in wound care having witnessed significant quality of care issues associated with negative pressure devices.
Mr. Brad Cleaver
Channel Sales Director
Brad Cleaver is a Medical Sales Executive with over 20 years of accomplishments in both the Pharmaceutical arena and the Diagnostic Laboratory space. Brad has led the launch of multiple cutting edge pharmaceutical medications and helped to build a multimillion dollar medical laboratory. Brad is C-Suite specialist with vision for success, growth and exit strategies.